HSBC Holdings
AERI

HSBC Holdings’s Aerie Pharmaceuticals AERI Stock Holding History

HSBC Holdings’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,248
Closed -$120K – 3391
2022
Q2 		$120K Sell
16,248
-1,097
-6% -$7.73K ﹤0.01% 3008
2022
Q1 		$159K Buy
+17,345
New +$134K ﹤0.01% 3039
2021
Q1 		– Sell
-22,407
Closed -$302K – 3248
2020
Q4 		$302K Buy
22,407
+6,123
+38% +$74K ﹤0.01% 2563
2020
Q3 		$193K Sell
16,284
-1,738
-10% -$21.2K ﹤0.01% 2486
2020
Q2 		$266K Buy
+18,022
New +$267K ﹤0.01% 2188
2019
Q4 		– Sell
-25,616
Closed -$492K – 3245
2019
Q3 		$492K Buy
+25,616
New +$587K ﹤0.01% 2352

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings's AERI Position: Q3 2022 in Review

HSBC Holdings sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 16,248 shares — an estimated $120K sold.

HSBC Holdings first reported a position in AERI in Q3 2019 and held it in 6 quarters. The position peaked at $492K in Q3 2019. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • HSBC Holdings reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • HSBC Holdings sold 16,248 Aerie Pharmaceuticals shares in Q3 2022, an estimated $120K.
  • HSBC Holdings first reported a position in Aerie Pharmaceuticals in Q3 2019 and held it in 6 quarters.
  • HSBC Holdings's Aerie Pharmaceuticals position peaked at $492K in Q3 2019.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.